3
|
Alcântara ACS, Assis I, Prada D, Mehle K, Schwan S, Costa-Paiva L, Skaf MS, Wrobel LC, Sollero P. Patient-Specific Bone Multiscale Modelling, Fracture Simulation and Risk Analysis-A Survey. MATERIALS (BASEL, SWITZERLAND) 2019; 13:E106. [PMID: 31878356 PMCID: PMC6981613 DOI: 10.3390/ma13010106] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/13/2019] [Revised: 12/16/2019] [Accepted: 12/17/2019] [Indexed: 12/26/2022]
Abstract
This paper provides a starting point for researchers and practitioners from biology, medicine, physics and engineering who can benefit from an up-to-date literature survey on patient-specific bone fracture modelling, simulation and risk analysis. This survey hints at a framework for devising realistic patient-specific bone fracture simulations. This paper has 18 sections: Section 1 presents the main interested parties; Section 2 explains the organzation of the text; Section 3 motivates further work on patient-specific bone fracture simulation; Section 4 motivates this survey; Section 5 concerns the collection of bibliographical references; Section 6 motivates the physico-mathematical approach to bone fracture; Section 7 presents the modelling of bone as a continuum; Section 8 categorizes the surveyed literature into a continuum mechanics framework; Section 9 concerns the computational modelling of bone geometry; Section 10 concerns the estimation of bone mechanical properties; Section 11 concerns the selection of boundary conditions representative of bone trauma; Section 12 concerns bone fracture simulation; Section 13 presents the multiscale structure of bone; Section 14 concerns the multiscale mathematical modelling of bone; Section 15 concerns the experimental validation of bone fracture simulations; Section 16 concerns bone fracture risk assessment. Lastly, glossaries for symbols, acronyms, and physico-mathematical terms are provided.
Collapse
Affiliation(s)
- Amadeus C. S. Alcântara
- Department of Computational Mechanics, School of Mechanical Engineering, University of Campinas—UNICAMP, Campinas, Sao Paulo 13083-860, Brazil; (A.C.S.A.); (D.P.)
| | - Israel Assis
- Department of Integrated Systems, School of Mechanical Engineering, University of Campinas—UNICAMP, Campinas, Sao Paulo 13083-860, Brazil;
| | - Daniel Prada
- Department of Computational Mechanics, School of Mechanical Engineering, University of Campinas—UNICAMP, Campinas, Sao Paulo 13083-860, Brazil; (A.C.S.A.); (D.P.)
| | - Konrad Mehle
- Department of Engineering and Natural Sciences, University of Applied Sciences Merseburg, 06217 Merseburg, Germany;
| | - Stefan Schwan
- Fraunhofer Institute for Microstructure of Materials and Systems IMWS, 06120 Halle/Saale, Germany;
| | - Lúcia Costa-Paiva
- Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas—UNICAMP, Campinas, Sao Paulo 13083-887, Brazil;
| | - Munir S. Skaf
- Institute of Chemistry and Center for Computing in Engineering and Sciences, University of Campinas—UNICAMP, Campinas, Sao Paulo 13083-860, Brazil;
| | - Luiz C. Wrobel
- Institute of Materials and Manufacturing, Brunel University London, Uxbridge UB8 3PH, UK;
- Department of Civil and Environmental Engineering, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro 22451-900, Brazil
| | - Paulo Sollero
- Department of Computational Mechanics, School of Mechanical Engineering, University of Campinas—UNICAMP, Campinas, Sao Paulo 13083-860, Brazil; (A.C.S.A.); (D.P.)
| |
Collapse
|
6
|
Nebot E, Aparicio VA, Coll-Risco I, Camiletti-Moirón D, Schneider J, Kapravelou G, Heimel P, Martínez R, Andrade A, Slezak P, Redl H, Porres JM, López-Jurado M, Pietschmann P, Aranda P. Effects of a moderately high-protein diet and interval aerobic training combined with strength-endurance exercise on markers of bone metabolism, microarchitecture and turnover in obese Zucker rats. Bone 2016; 92:116-123. [PMID: 27554427 DOI: 10.1016/j.bone.2016.08.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Revised: 08/16/2016] [Accepted: 08/19/2016] [Indexed: 01/21/2023]
Abstract
BACKGROUND Weight loss is a public health concern in obesity-related diseases such as metabolic syndrome, and the protein level of the diets seem to be crucial for the development and maintenance of bone. The nature of exercise and whether exercise in combination with moderately high-protein dietary interventions could protect against potential bone mass deficits remains unclear. OBJECTIVES To investigate the effects of a moderately high-protein diet and interval aerobic training combined with strength-endurance exercise (IASE) protocol on bone status, and to assess potential interaction effects (i.e. diet*IASE). METHODS Male Zucker fatty rats were randomized distributed into 4 groups (n=8): normoprotein+sedentary; normoprotein+exercise; moderately high-protein+sedentary, and moderately high-protein+exercise. Training groups conducted an IASE program, 5days/week for 2months. Markers of bone metabolism were measured in plasma. Parameters of bone mass and 3D outcomes for trabecular and cortical bone microarchitecture were assessed by micro-computed tomography. RESULTS Femur length, plasma osteocalcin, sclerostin, osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, insulin, leptin, PTH, uric acid and urinary phosphorus levels were lower in the moderately high-protein compared to the normoprotein groups (all, p<0.05), whereas plasma alkaline phosphatase, aspartate aminotransferase, alanine transaminase, and urinary uric acid concentrations, and cortical total volume (TV) and bone volume (BV) were higher in the moderately high-protein (all, p<0.01). Final body weight and alkaline phosphatase levels were lower in the exercise compared to the sedentary (both, p<0.05), whereas femur length and weight, aminoterminal propeptides of type I procollagen and C-terminal telopeptides of type I collagen concentrations, and cortical TV and BV were higher in the exercise compared to the sedentary groups (all, p<0.05). CONCLUSION The combination of interventions may be effective to enhance trabecular bone microarchitecture and BMD, and has a partial impact on cortical bone in obese rats. Nevertheless, they do not induce any alteration on the bone turnover markers.
Collapse
Affiliation(s)
- Elena Nebot
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain; Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Austria.
| | - Virginia A Aparicio
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain; Department of Public and Occupational Health, EMGO(+) Institute for Health and Care Research, VU University Medical Centre, Amsterdam, The Netherlands
| | - Irene Coll-Risco
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain
| | - Daniel Camiletti-Moirón
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain; Department of Physical Education, School of Education, University of Cádiz, Spain
| | - Johannes Schneider
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain
| | - Garyfallia Kapravelou
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain
| | - Patrick Heimel
- Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for Tissue Regeneration, AUVA Research Center, Vienna, Austria; Karl Donath Laboratory for Hard Tissue and Biomaterial Research, Department of Oral Surgery, Medical University of Vienna, Vienna, Austria
| | - Rosario Martínez
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain
| | - Ana Andrade
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain
| | - Paul Slezak
- Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for Tissue Regeneration, AUVA Research Center, Vienna, Austria
| | - Heinz Redl
- Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Austrian Cluster for Tissue Regeneration, AUVA Research Center, Vienna, Austria
| | - Jesús M Porres
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain
| | - María López-Jurado
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain
| | - Peter Pietschmann
- Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Austria
| | - Pilar Aranda
- Department of Physiology, Faculty of Pharmacy, Institute of Nutrition and Food Technology, University of Granada, Spain
| |
Collapse
|
7
|
Naot D, Watson M, Callon KE, Tuari D, Musson DS, Choi AJ, Sreenivasan D, Fernandez J, Tu PT, Dickinson M, Gamble GD, Grey A, Cornish J. Reduced Bone Density and Cortical Bone Indices in Female Adiponectin-Knockout Mice. Endocrinology 2016; 157:3550-61. [PMID: 27384302 DOI: 10.1210/en.2016-1059] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
A positive association between fat and bone mass is maintained through a network of signaling molecules. Clinical studies found that the circulating levels of adiponectin, a peptide secreted from adipocytes, are inversely related to visceral fat mass and bone mineral density, and it has been suggested that adiponectin contributes to the coupling between fat and bone. Our study tested the hypothesis that adiponectin affects bone tissue by comparing the bone phenotype of wild-type and adiponectin-knockout (APN-KO) female mice between the ages of 8-37 weeks. Using a longitudinal study design, we determined body composition and bone density using dual energy x-ray absorptiometry. In parallel, groups of animals were killed at different ages and bone properties were analyzed by microcomputed tomography, dynamic histomorphometry, 3-point bending test, nanoindentation, and computational modelling. APN-KO mice had reduced body fat and decreased whole-skeleton bone mineral density. Microcomputed tomography analysis identified reduced cortical area fraction and average cortical thickness in APN-KO mice in all the age groups and reduced trabecular bone volume fraction only in young APN-KO mice. There were no major differences in bone strength and material properties between the 2 groups. Taken together, our results demonstrate a positive effect of adiponectin on bone geometry and density in our mouse model. Assuming adiponectin has similar effects in humans, the low circulating levels of adiponectin associated with increased fat mass are unlikely to contribute to the parallel increase in bone mass. Therefore, adiponectin does not appear to play a role in the coupling between fat and bone tissue.
Collapse
Affiliation(s)
- Dorit Naot
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Maureen Watson
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Karen E Callon
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Donna Tuari
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - David S Musson
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Ally J Choi
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Dharshini Sreenivasan
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Justin Fernandez
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Pao Ting Tu
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Michelle Dickinson
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Greg D Gamble
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Andrew Grey
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| | - Jillian Cornish
- Department of Medicine (D.N., M.W., K.E.C., D.T., D.S.M., A.J.C., G.D.G., A.G., J.C.), University of Auckland, Auckland 1142, New Zealand; Auckland Bioengineering Institute (D.S., J.F.), University of Auckland, Auckland 1142, New Zealand; Department of Engineering Science (J.F.), University of Auckland, Auckland 1142, New Zealand; and Department of Chemical and Materials Engineering (P.T.T., M.D.), University of Auckland, Auckland 1142, New Zealand
| |
Collapse
|